Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHgCapital Trust plc Regulatory News (HGT)

Share Price Information for HgCapital Trust plc (HGT)

Share Price is delayed by 15 minutes
Get Live Data
409.50    23.50 (6.09%)
Bid:
406.50
Ask:
410.00
Spread: 3.50 (0.861%)
Market Cap: £1.86b
HGT Live PriceLast checked at - London Stock Exchange

Intraday HgCapital Trust plc Share Chart

Half Yearly Report

23 Aug 2012 07:00

RNS Number : 6033K
HgCapital Trust plc
23 August 2012
 



HgCapital Trust plc

Interim Results for the six months ended 30 June 2012

 

 

London, 23 August 2012: HgCapital Trust plc ("the Trust"), which provides investors with a listed vehicle to invest in all private equity deals managed by HgCapital, today announces its interim results for the six months ended 30 June 2012.

 

 

HgCAPITAL TRUST PLC CONTINUES TO DELIVER LONG TERM OUTPERFORMANCE

 

Summary performance for six months to 30 June 2012 and pro-forma results taking into account three realisations since the period end detailed below

 

Pro-forma

30 June 2012 as reported

% Total return*

Adjusted

% Total return*

Actual

NAV per share

(diluted)

+10.1%

1,166.9p

+7.4%

1,138.3p

(basic)

+11.5%

1,204.4p

+8.4%

1,170.8p

Share price

-6.1%

901.0p

FTSE All-Share Index

+3.3%

Movement

Movement

NAV

+£36.5m

£383.3m

+£25.8m

£372.6m

* Assuming reinvestment of all dividends

 

 

§ +14.4% p.a. 10-year compound annual growth rate of the share price on a total return basis vs. +6.1% p.a. from the FTSE All-Share Index on a total return basis to 30 June 2012.

 

§ Strong Sales and EBITDA growth from top 20 buyout investments of +11% and +12% respectively over last 12 months to 30 June 2012.

 

§ Three realisations agreed since the period end (SHL, Mercury Pharma and RPP1's UK Wind operating assets) with a total consideration of £69.1 million.

- Sale of SHL agreed, at a 3.1x investment multiple with cash proceeds of £26.8 million.

 

- Sale of RPP1's UK wind platform, at a 2.0x investment multiple will return £5.9 million to the Trust

 

- Sale of Mercury Pharma agreed at a 4.1x investment multiple (potentially rising to 4.3x), with a cash consideration of £35.4 million and further potential proceeds of £1.0 million over the next 30 months.

 

§ Pro-forma liquid resources post these transactions will be approximately £130 million (34% of pro forma NAV) with outstanding commitments of £179.1 million (47% of pro-forma NAV).

 

Manager Outlook

 

§ Despite the weak macro-economic environment across Western Europe we believe that our investment strategy of identifying high quality growth companies in market niches will continue to benefit the performance of our portfolio.

 

§ We remain relatively cautious on new investment although within our sectors of expertise we continue to find opportunities to acquire market leading businesses at reasonable prices.

 

§ As recently evidenced, we continue to see an active interest in acquiring a number of our portfolio companies which may lead us to realise a number of our investments over the next 18 months.

 

§ Owning a portfolio of quality growth companies run by talented managers should continue to build significant shareholder value over the medium-term.

 

 

Roger Mountford, Chairman of the Trust, commented:

 

"The Trust is well positioned, with a balance of assets that are steadily creating value under HgCapital's management and a pipeline of new investment opportunities. The portfolio continues to deliver double digit revenue and profit growth year on year. The Trust's record of rewarding long-term investors continues to justify investment".

 

- Ends -

 

The full Interim Results and a webcast describing the results are available at http://www.hgcapitaltrust.com/.

 

For further details:

HgCapital

Nic Humphries (CEO, HgCapital)

+44 (0)20 7089 7888

Roger Mountford (Chairman, HgCapital Trust plc)

Maitland

+44 (0) 77 99 66 26 01

Rowan Brown

George Hudson

+44 (0)20 7379 5151

 

About HgCapital Trust plc

 

HgCapital Trust plc is an investment trust whose shares are listed on the London Stock Exchange. The Trust gives investors exposure, through a liquid vehicle, to a portfolio of high-growth private companies, managed by HgCapital, an experienced and well-resourced private equity firm with a long-term track record of delivering superior risk-adjusted returns for its investors.

 

For further details, see www.hgcapitaltrust.com and www.hgcapital.com

 

Neither the contents of HgCapital's website, HgCapital Trust's website nor the contents of any website accessible from hyperlinks on the websites (or any other website) is incorporated into, or forms part of, this announcement.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR PGUPPRUPPGMP
Date   Source Headline
4th Jun 20267:02 amRNSHg to increase strategic investment in HgT
27th May 20267:00 amRNSHg announces an investment in Rightsline
15th May 20265:11 pmRNSDirector/PDMR Shareholding
7th May 20262:38 pmRNSResult of AGM & Directorate Changes
7th May 20267:00 amRNS1st Quarter Results
1st May 202610:41 amRNSTotal Voting Rights
29th Apr 20265:34 pmRNSTransaction in Own Shares
27th Apr 20265:22 pmRNSTransaction in Own Shares
24th Apr 20265:33 pmRNSTransaction in Own Shares
23rd Apr 20265:16 pmRNSTransaction in Own Shares
16th Apr 20265:29 pmRNSTransaction in Own Shares
16th Apr 20268:52 amRNSDirector Declaration
10th Apr 20265:24 pmRNSTransaction in Own Shares
9th Apr 20265:50 pmRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20265:16 pmRNSTransaction in Own Shares
30th Mar 20265:41 pmRNSHg announces the full exit of Geomatikk Group
30th Mar 20265:24 pmRNSTransaction in Own Shares
27th Mar 20265:15 pmRNSTransaction in Own Shares
26th Mar 20265:02 pmRNSTransaction in Own Shares
25th Mar 20265:58 pmRNSTransaction in Own Shares
24th Mar 20265:06 pmRNSTransaction in Own Shares
20th Mar 20265:22 pmRNSTransaction in Own Shares
19th Mar 20265:14 pmRNSTransaction in Own Shares
18th Mar 20265:40 pmRNSTransaction in Own Shares
17th Mar 20265:05 pmRNSTransaction in Own Shares
16th Mar 20265:18 pmRNSTransaction in Own Shares
13th Mar 20265:04 pmRNSTransaction in Own Shares
13th Mar 20261:46 pmRNS-REdison issues report on HgT (HGT)
12th Mar 20265:11 pmRNSTransaction in Own Shares
12th Mar 20264:29 pmRNSHolding(s) in Company
10th Mar 20265:15 pmRNSTransaction in Own Shares
9th Mar 20267:00 amRNSAnnual Financial Report
6th Mar 20265:35 pmRNSTransaction in Own Shares
4th Mar 20265:44 pmRNSTransaction in Own Shares
3rd Mar 20265:15 pmRNSTransaction in Own Shares
2nd Mar 20265:45 pmRNSTransaction in Own Shares
2nd Mar 202610:07 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSNew co-investments in OneStream and Septeo
27th Feb 20265:03 pmRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20263:20 pmRNSHolding(s) in Company
24th Feb 20265:08 pmRNSTransaction in Own Shares
23rd Feb 20265:15 pmRNSTransaction in Own Shares
23rd Feb 20264:09 pmRNSHolding(s) in Company
20th Feb 20265:26 pmRNSTransaction in Own Shares
19th Feb 20265:08 pmRNSTransaction in Own Shares
19th Feb 20264:16 pmRNSHolding(s) in Company
18th Feb 20265:06 pmRNSTransaction in Own Shares
18th Feb 20264:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.